{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:44:33Z","timestamp":1790538273333,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["17107019"],"award-info":[{"award-number":["17107019"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","award":["17107019"],"award-info":[{"award-number":["17107019"]}],"id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Emerging variants of SARS-CoV-2 have been shown to rapidly replace original circulating strains in humans soon after they emerged. There is a lack of experimental evidence to explain how these natural occurring variants spread more efficiently than existing strains of SARS-CoV-2 in transmission. We found that the Alpha variant (B.1.1.7) increased competitive fitness over earlier parental D614G lineages in in-vitro and in-vivo systems. Using hamster transmission model, we further demonstrated that the Alpha variant is able to replicate and shed more efficiently in the nasal cavity of hamsters than other variants with low dose and short duration of exposure. The capability to initiate effective infection with low inocula may be one of the key factors leading to the rapid transmission of emerging variants of SARS-CoV-2.<\/jats:p>","DOI":"10.1038\/s42003-021-02640-x","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T10:02:53Z","timestamp":1632132173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamsters"],"prefix":"10.1038","volume":"4","author":[{"given":"Bobo Wing-Yee","family":"Mok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaofeng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5087-3614","authenticated-orcid":false,"given":"Anna Jinxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siu-Ying","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Chun-Yee","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor J.","family":"Cremin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Ting-Leung","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-8282","authenticated-orcid":false,"given":"Jake Siu-Lun","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lam-Kwong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1921-5824","authenticated-orcid":false,"given":"Kelvin Kai-Wang","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper Fuk-Woo","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-Hung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2083-1552","authenticated-orcid":false,"given":"Kwok-Yung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilman Kit-Hang","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5108-8338","authenticated-orcid":false,"given":"Honglin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"2640_CR1","unstructured":"England Public Health. Investigation of novel SARS-CoV-2 Variants of Concern. https:\/\/www.gov.uk\/government\/publications\/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201 (2020)."},{"key":"2640_CR2","unstructured":"O\u2019Toole, A., Hill, V., Pybus, O. G. Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351\/501Y-V2. https:\/\/virological.org\/t\/tracking-the-international-spread-of-sars-cov-2-lineages-b-1-1-7-and-b-1-351-501y-v2\/592 (2021)."},{"key":"2640_CR3","doi-asserted-by":"publisher","first-page":"2100256","DOI":"10.2807\/1560-7917.ES.2021.26.11.2100256","volume":"26","author":"DJ Grint","year":"2021","unstructured":"Grint, D. J. et al. Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England. Eur. Surveill. 26, 2100256 (2021).","journal-title":"Eur. Surveill."},{"key":"2640_CR4","first-page":"6538","volume":"9","author":"NG Davies","year":"2021","unstructured":"Davies, N. G. et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science 9, 6538 (2021).","journal-title":"Science"},{"key":"2640_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-021-03426-1","volume":"593","author":"NG Davies","year":"2021","unstructured":"Davies, N. G. et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature 593, 270\u2013274 (2021).","journal-title":"Nature"},{"key":"2640_CR6","unstructured":"Rambaut, A. et al. Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. https:\/\/virological.org\/t\/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations\/563 (2020)"},{"key":"2640_CR7","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","volume":"3","author":"TN Starr","year":"2020","unstructured":"Starr, T. N. et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 3, 1295\u20131310 (2020).","journal-title":"Cell"},{"key":"2640_CR8","first-page":"109292","volume":"29","author":"S Kemp","year":"2021","unstructured":"Kemp, S. et al. Recurrent emergence of SARS-CoV-2 spike deletion H69\/V70 and its role in the Alpha variant B.1.1.7. Cell Rep. 29, 109292 (2021).","journal-title":"Cell Rep."},{"key":"2640_CR9","doi-asserted-by":"publisher","unstructured":"Tian, F. et al. Mutation N501Y in RBD of Spike Protein Strengthens the Interaction between COVID-19 and its Receptor ACE2. bioRxiv. https:\/\/doi.org\/10.1101\/2021.02.14.431117 (2021).","DOI":"10.1101\/2021.02.14.431117"},{"key":"2640_CR10","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. The N501Y spike substitution enhances SARS-CoV-2 transmission. bioRxiv. https:\/\/doi.org\/10.1101\/2021.03.08.434499 (2021).","DOI":"10.1101\/2021.03.08.434499"},{"key":"2640_CR11","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.cell.2021.02.032","volume":"15","author":"W Dejnirattisai","year":"2021","unstructured":"Dejnirattisai, W. et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell 15, 2183\u20132200 (2021).","journal-title":"Cell"},{"key":"2640_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","volume":"78","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M., Kleine-Weber, H. & Pohlmann, S. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. Mol. Cell 78, 779\u2013784 (2020).","journal-title":"Mol. Cell"},{"key":"2640_CR13","first-page":"15651","volume":"2","author":"M Seyran","year":"2020","unstructured":"Seyran, M. et al. The structural basis of accelerated host cell entry by SARS-CoV-2\u2020. Febs j. 2, 15651 (2020).","journal-title":"Febs j."},{"key":"2640_CR14","unstructured":"Faria, N. R., Claro, I. M., Candido, D. Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: preliminary findings. https:\/\/virological.org\/t\/genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-manaus-preliminary-findings\/586 (2021)."},{"key":"2640_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41586-021-03402-9","volume":"592","author":"H Tegally","year":"2021","unstructured":"Tegally, H. et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature 592, 438\u2013443 (2021).","journal-title":"Nature"},{"key":"2640_CR16","doi-asserted-by":"publisher","first-page":"103403","DOI":"10.1016\/j.ebiom.2021.103403","volume":"68","author":"R Abdelnabi","year":"2021","unstructured":"Abdelnabi, R. et al. Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters. EBioMedicine 68, 103403 (2021).","journal-title":"EBioMedicine"},{"key":"2640_CR17","doi-asserted-by":"publisher","unstructured":"Mohandas, S. et al. Comparison of the pathogenicity and virus shedding of SARS CoV-2 VOC 202012\/01 and D614G variant in hamster model. bioRxiv. https:\/\/doi.org\/10.1101\/2021.02.25.432136 (2021).","DOI":"10.1101\/2021.02.25.432136"},{"key":"2640_CR18","first-page":"2428","volume":"3","author":"JF Chan","year":"2020","unstructured":"Chan, J. F. et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin. Infect. Dis. 3, 2428\u20132446 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"2640_CR19","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1073\/pnas.2018975117","volume":"117","author":"M Imai","year":"2020","unstructured":"Imai, M. et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc. Natl Acad. Sci. USA 117, 16587\u201316595 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2640_CR20","doi-asserted-by":"publisher","unstructured":"Thorne, L. G. et al. Evolution of enhanced innate immune evasion by the SARS-CoV-2 B.1.1.7 UK variant. bioRxiv. https:\/\/doi.org\/10.1101\/2021.06.06.446826 (2021).","DOI":"10.1101\/2021.06.06.446826"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02640-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02640-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02640-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T19:44:55Z","timestamp":1670096695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02640-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2640"],"URL":"https:\/\/doi.org\/10.1038\/s42003-021-02640-x","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1102"}}